DK173480B1 - Fremgangsmåde til fremstilling af præparatformer af aktive stoffer med tidsstyret frigivelse ud fra præparater af aktive st - Google Patents
Fremgangsmåde til fremstilling af præparatformer af aktive stoffer med tidsstyret frigivelse ud fra præparater af aktive st Download PDFInfo
- Publication number
- DK173480B1 DK173480B1 DK198202879A DK287982A DK173480B1 DK 173480 B1 DK173480 B1 DK 173480B1 DK 198202879 A DK198202879 A DK 198202879A DK 287982 A DK287982 A DK 287982A DK 173480 B1 DK173480 B1 DK 173480B1
- Authority
- DK
- Denmark
- Prior art keywords
- release
- preparations
- viscosity
- preparation
- active
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000203 mixture Substances 0.000 title claims description 18
- 239000004480 active ingredient Substances 0.000 title claims description 4
- 239000013543 active substance Substances 0.000 title abstract description 6
- 238000013270 controlled release Methods 0.000 title abstract description 3
- 229920001477 hydrophilic polymer Polymers 0.000 claims abstract description 12
- 238000013268 sustained release Methods 0.000 claims abstract description 5
- 239000012730 sustained-release form Substances 0.000 claims abstract description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 17
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 17
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 11
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 229920000609 methyl cellulose Polymers 0.000 claims description 3
- 239000001923 methylcellulose Substances 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 230000000630 rising effect Effects 0.000 abstract 1
- 239000011149 active material Substances 0.000 description 20
- 230000003111 delayed effect Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000000654 additive Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 230000004580 weight loss Effects 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- FEDJGPQLLNQAIY-UHFFFAOYSA-N 2-[(6-oxo-1h-pyridazin-3-yl)oxy]acetic acid Chemical compound OC(=O)COC=1C=CC(=O)NN=1 FEDJGPQLLNQAIY-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical group OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940096529 carboxypolymethylene Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 229920006184 cellulose methylcellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229960005316 diltiazem hydrochloride Drugs 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- GBCAVSYHPPARHX-UHFFFAOYSA-M n'-cyclohexyl-n-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]methanediimine;4-methylbenzenesulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1CCCCC1N=C=NCC[N+]1(C)CCOCC1 GBCAVSYHPPARHX-UHFFFAOYSA-M 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000012958 reprocessing Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229960004029 silicic acid Drugs 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
- A01N25/10—Macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- C—CHEMISTRY; METALLURGY
- C05—FERTILISERS; MANUFACTURE THEREOF
- C05G—MIXTURES OF FERTILISERS COVERED INDIVIDUALLY BY DIFFERENT SUBCLASSES OF CLASS C05; MIXTURES OF ONE OR MORE FERTILISERS WITH MATERIALS NOT HAVING A SPECIFIC FERTILISING ACTIVITY, e.g. PESTICIDES, SOIL-CONDITIONERS, WETTING AGENTS; FERTILISERS CHARACTERISED BY THEIR FORM
- C05G3/00—Mixtures of one or more fertilisers with additives not having a specially fertilising activity
- C05G3/40—Mixtures of one or more fertilisers with additives not having a specially fertilising activity for affecting fertiliser dosage or release rate; for affecting solubility
- C05G3/44—Mixtures of one or more fertilisers with additives not having a specially fertilising activity for affecting fertiliser dosage or release rate; for affecting solubility for affecting solubility
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Chemical & Material Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Materials For Medical Uses (AREA)
- Lock And Its Accessories (AREA)
- Slot Machines And Peripheral Devices (AREA)
- Valve-Gear Or Valve Arrangements (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19813125178 DE3125178A1 (de) | 1981-06-26 | 1981-06-26 | Verfahren zur zeitlichen steuerung der freisetzung von wirkstoffen aus wirkstoffzubereitungen, insbesondere arzneimittelzubereitungen |
| DE3125178 | 1981-06-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK287982A DK287982A (da) | 1982-12-27 |
| DK173480B1 true DK173480B1 (da) | 2000-12-18 |
Family
ID=6135462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK198202879A DK173480B1 (da) | 1981-06-26 | 1982-06-25 | Fremgangsmåde til fremstilling af præparatformer af aktive stoffer med tidsstyret frigivelse ud fra præparater af aktive st |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0068446B2 (es) |
| JP (1) | JPS5843927A (es) |
| AT (1) | ATE16979T1 (es) |
| AU (1) | AU548792B2 (es) |
| CA (1) | CA1208556A (es) |
| DE (2) | DE3125178A1 (es) |
| DK (1) | DK173480B1 (es) |
| ES (1) | ES8308699A1 (es) |
| FI (1) | FI78391C (es) |
| HU (1) | HU189148B (es) |
| IE (1) | IE53104B1 (es) |
| SU (1) | SU1375114A3 (es) |
| ZA (1) | ZA824496B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8403360D0 (en) * | 1984-02-08 | 1984-03-14 | Erba Farmitalia | Pharmaceutical compositions |
| GB8403361D0 (en) * | 1984-02-08 | 1984-03-14 | Erba Farmitalia | Pharmaceutical composition |
| US4608248A (en) * | 1985-11-08 | 1986-08-26 | Warner-Lambert Company | Process for time-controlled release of active ingredients |
| DE3737741A1 (de) * | 1987-11-06 | 1989-05-18 | Goedecke Ag | Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid |
| FR2630913A1 (fr) * | 1988-05-09 | 1989-11-10 | Delalande Sa | Comprimes de sel(s) hydrosoluble(s) de diltiazem a liberation programmee et leur procede de fabrication |
| ES2036123B1 (es) * | 1990-12-03 | 1994-01-16 | Neila Nieto Jorge Juan | Proceso de fabricacion de fertilizantes inorganicos solidos acondicionados con polimeros retenedores de agua. |
| ES2042418B1 (es) * | 1992-05-18 | 1994-07-01 | Tecno Holding S A | Metodo para el tratamiento externo de los cultivos vegetales. |
| US6440457B1 (en) | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
| GB2370775A (en) * | 2001-01-04 | 2002-07-10 | Nimrod Israely | Insecticidal composition based on attractant, insecticide and stabilizer, the outer surface of which expands & loses viscosity on contact with humidity |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1492019A1 (de) * | 1963-06-20 | 1969-02-20 | Ministerul Ind Petrolului Si C | Zuschlag fuer Arzneimitteltabletten und Verfahren zu ihrer Gewinnung |
| NL159577B (nl) * | 1968-02-15 | 1979-03-15 | Organon Nv | Werkwijze ter bereiding van snel desintegrerende vaste vormstukken. |
| GB2042888B (en) * | 1979-03-05 | 1983-09-28 | Teijin Ltd | Preparation for administration to the mucosa of the oral or nasal cavity |
| US4226849A (en) * | 1979-06-14 | 1980-10-07 | Forest Laboratories Inc. | Sustained release therapeutic compositions |
| US4259314A (en) * | 1979-12-10 | 1981-03-31 | Hans Lowey | Method and composition for the preparation of controlled long-acting pharmaceuticals |
-
1981
- 1981-06-26 DE DE19813125178 patent/DE3125178A1/de not_active Ceased
-
1982
- 1982-05-19 IE IE1201/82A patent/IE53104B1/en not_active IP Right Cessation
- 1982-06-21 SU SU823452763A patent/SU1375114A3/ru active
- 1982-06-24 EP EP82105557A patent/EP0068446B2/de not_active Expired
- 1982-06-24 AT AT82105557T patent/ATE16979T1/de active
- 1982-06-24 DE DE8282105557T patent/DE3268012D1/de not_active Expired
- 1982-06-24 FI FI822276A patent/FI78391C/fi not_active IP Right Cessation
- 1982-06-24 ZA ZA824496A patent/ZA824496B/xx unknown
- 1982-06-25 DK DK198202879A patent/DK173480B1/da active
- 1982-06-25 ES ES513422A patent/ES8308699A1/es not_active Expired
- 1982-06-25 HU HU822074A patent/HU189148B/hu unknown
- 1982-06-25 CA CA000406024A patent/CA1208556A/en not_active Expired
- 1982-06-25 AU AU85361/82A patent/AU548792B2/en not_active Expired
- 1982-06-25 JP JP57108599A patent/JPS5843927A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ES513422A0 (es) | 1983-10-01 |
| JPH0569806B2 (es) | 1993-10-01 |
| AU548792B2 (en) | 1986-01-02 |
| ES8308699A1 (es) | 1983-10-01 |
| DE3125178A1 (de) | 1983-01-13 |
| EP0068446B1 (de) | 1985-12-18 |
| JPS5843927A (ja) | 1983-03-14 |
| IE53104B1 (en) | 1988-06-22 |
| EP0068446A3 (en) | 1983-07-20 |
| FI822276A0 (fi) | 1982-06-24 |
| DK287982A (da) | 1982-12-27 |
| ZA824496B (en) | 1983-04-27 |
| ATE16979T1 (de) | 1986-01-15 |
| EP0068446B2 (de) | 1988-12-07 |
| EP0068446A2 (de) | 1983-01-05 |
| CA1208556A (en) | 1986-07-29 |
| AU8536182A (en) | 1983-01-06 |
| SU1375114A3 (ru) | 1988-02-15 |
| IE821201L (en) | 1982-12-26 |
| HU189148B (en) | 1986-06-30 |
| DE3268012D1 (en) | 1986-01-30 |
| FI822276L (fi) | 1982-12-27 |
| FI78391B (fi) | 1989-04-28 |
| FI78391C (fi) | 1989-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK173480B1 (da) | Fremgangsmåde til fremstilling af præparatformer af aktive stoffer med tidsstyret frigivelse ud fra præparater af aktive st | |
| US3362881A (en) | Sustained release tablet and method of manufacturing same | |
| EP0188040B1 (en) | Slow release solid preparation | |
| US3539380A (en) | Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms | |
| US3922339A (en) | Sustained release medicant | |
| CA1297409C (en) | Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics | |
| JPH10505604A (ja) | メトホルミンを含有する医薬調製物およびそれを製造する方法 | |
| JPS637531B2 (es) | ||
| BG106626A (bg) | Таблета с директно пресовано полимерно ядро | |
| US4608248A (en) | Process for time-controlled release of active ingredients | |
| EP0143603B1 (en) | Sugar-coated pharmaceutical composition and method for preparing the same | |
| US2897122A (en) | Enteric coated product | |
| CN102573835A (zh) | 变色和气味得到抑制的膜包衣片 | |
| US5132295A (en) | Alginate-based verapamil-containing depot drug form | |
| Jawed et al. | Formulation and Evaluation of Orodispersible Tablet of Cefixime trihydrate by using Fenugreek Mucilage as a Superdisintegrant | |
| DK144261B (es) | ||
| NO131864B (es) | ||
| RU2149001C1 (ru) | Ноотропное лекарственное средство и способ его получения | |
| DK143247B (da) | Medicinsk tablet indeholdende som aktiv bestanddel en 2,4-diamino-5-benzylpyrimidin sammen med et sulfonamid | |
| Ng Thing Wei et al. | The effects of the combination of biodegradable and synthetic polymers on the release behaviour of Nateglinide matrix tablets. | |
| JP2021506750A (ja) | アカルボースおよびメトホルミンの固定用量組合せ錠剤製剤およびその製造方法 | |
| Mahesh et al. | FORMULATION DEVELOPMENT AND INVITRO EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM OF LABETALOL | |
| Rahela et al. | Formulation and evaluation of polymer effect on in-vitro kinetics of sustained release matrix tablets of carvedilol using model dependent methods | |
| Abdullah-Al-Mamun et al. | Formulation and Bioequivalence Evaluation of Extended Release Solid Drug Delivery System for Metronidazole Using Eudragit NM30D and Methocel Premium K4M as Retardant Material | |
| Ahmed et al. | Development of sustained release matrix tablets of ramipril and evaluation of polymer effect on in-vitro release pattern |